Here you’ll find a growing body of knowledge researched and written by our clinical staff and by key educational partners.
Do you wonder about the role that microbes play when you see conditions related to inflammation? In this series, Kristen Klos-Maki, DC, dives into the science that explains how overgrowth of harmful bacteria generates inflammation, and why inflammatory issues improve when we address microbiome and gut health.
Learn MoreNow that we are aware of the microbiome, and its relationship to systemic inflammatory conditions, it becomes clear that regular evaluation of the microbiome is essential to achieve and maintain lasting therapeutic effects for our patients.
Learn MoreWhat if you could catch gut dysbiosis or increase microbial diversity before LPS became systemic and caused severe symptoms? Recent research supports the role botanicals play in producing short-chain fatty acids (SCFAs) and the modulation of gut microbiota composition, proving valuable tools to support patients with whole-body health.
Learn MoreGastrointestinal candidiasis (GC) is well-known to functional and integrative medicine providers. In this article, Kurt Woeller, DO, discusses various aspects of chronic candidiasis as it relates to different health conditions and explores different mechanisms of pathogenicity including arabinose toxicity, leaky gut (intestinal permeability), invasive protein, and immune deficiency.
Learn MoreBlood cultures for Candida, unfortunately, are often unreliable. Based on years of clinical experience, Kurt Woeller, DO, outlines laboratory test options for the detection of intestinal candida, as well as effective methods for analyzing the invasive nature of these fungal organisms.
Learn MoreInvasive Candida. What can be done about it? Kurt Woeller, DO, discusses three distinct categories of intervention: systemic, non-systemic, and botanical. He specifically explores two antifungal medications and five botanicals known to be helpful in addressing chronic candidiasis.
Learn MoreLyme and tick-borne illnesses are complex and challenging. To assist in patient evaluation, Emily Hernandez, ND, a Lyme-literate doctor and Biocidin® Clinical Consultant, provides a thorough overview of current thinking in the field, as well as symptom pictures, acute vs. chronic conditions, and common co-infections.
Learn MoreLyme is known as “The Great Imitator” because of its variety and complexity. Emily Hernandez, ND, a Lyme specialist, brings clarity to testing options to help practitioners identify when Lyme and its coinfections are the root cause of illness.
Learn More
Emily Hernandez, ND, a Lyme specialist with significant clinical experience, shares essential steps to support even the most sensitive and complex patients, simplifying and clarifying possible treatment strategies.
Learn MoreClostridium difficile is labeled as one of the organisms of greatest concern for antibiotic resistance by the National Institutes of Health. It can also colonize the gastrointestinal tract, creating chronic symptoms that are harder to recognize. In this first installment of a three-part series, Kurt Woeller, DO discusses the breadth of symptoms that can manifest with Clostridium difficile and other pathogenic species.
Learn MoreA growing body of evidence highlights the influence of the gut microbiota on lung immunity—the Gut-Lung Axis. In this article, Dr. Jocelyn Strand, Biocidin's Director of Clinical Research, summarizes current research focusing on the microbiome, the Gut-Lung Axis, and their roles in pulmonary health. She also discusses the role of botanicals in maintaining a oral and gut microbiome health.
Learn MoreRespiratory conditions are some of the most common issues seen in clinical practice. In 2016, chronic obstructive pulmonary disease (COPD) accounted for around 3 million deaths, and was the third leading cause of death worldwide.
Learn More
